GO:0043277 apoptotic cell clearance: Efferocytosis Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0043277 apoptotic cell clearance (efferocytosis) is the biological process by which dying apoptotic cells are recognized and removed by neighboring cells or professional phagocytes.
• Efferocytosis is essential for tissue homeostasis, resolution of inflammation, and prevention of autoimmunity; its failure is linked to atherosclerosis, fibrosis, and inflammaging.
• Key molecular players include phosphatidylserine receptors (MERTK, AXL, TYRO3), bridging molecules (MFGE8, GAS6), and metabolic regulators such as Piezo1 and arachidonic acid pathways.
• Recent studies show that efferocytosis is metabolically and mechanically regulated, with Piezo1 sensing stiffness to enhance macrophage clearance and promote liver fibrosis resolution.
• Defective clearance of senescent neutrophils by macrophages contributes to organ aging, and restoring this process limits age-related tissue deterioration.
• CRISPR-based models (knockout, knock-in, overexpression) are powerful tools to dissect the causal roles of efferocytosis genes in health and disease.
Description
Apoptotic cell clearance, also known as efferocytosis, is the biological process by which dying cells are recognized and removed by neighboring cells or professional phagocytes. This process is fundamental for normal tissue development, homeostasis, and the resolution of inflammation. Every day, billions of cells in the human body undergo apoptosis, and their efficient clearance prevents the release of toxic intracellular contents that could trigger inflammation and autoimmunity. The term GO:0043277 captures this entire sequence, from the recognition of apoptotic cells to their internalization and degradation. Researchers study apoptotic cell clearance because its dysregulation is implicated in a wide range of pathologies, including chronic inflammatory diseases, atherosclerosis, fibrosis, and age-related organ dysfunction. Understanding the molecular mechanisms of efferocytosis is therefore critical for developing new therapeutic strategies. Recent advances have highlighted the importance of mechanotransduction, metabolic reprogramming, and RNA modifications in regulating efferocytosis. This article provides a comprehensive overview of the genes, functions, and research methods associated with GO:0043277, based on authoritative QuickGO data and verified PubMed literature.
apoptotic cell clearance At A Glance
| GO ID | GO:0043277 |
|---|---|
| GO term | apoptotic cell clearance |
| Ontology | biological_process |
| Synonym | efferocytosis; apoptotic cell removal; programmed cell clearance |
| Major function | Recognition and removal of apoptotic cells by phagocytes or neighboring cells |
| Related diseases | Atherosclerosis, fibrosis, autoimmune disorders, inflammaging |
| Key cell types | Macrophages, dendritic cells, epithelial cells |
| Research methods | CRISPR knockout, live-cell imaging, flow cytometry, proteomics |
What Is GO:0043277?
According to the Gene Ontology, GO:0043277 apoptotic cell clearance is defined as the recognition and removal of an apoptotic cell by a neighboring cell or by a phagocyte. This process, also referred to as efferocytosis or programmed cell clearance, encompasses the molecular events that lead to the engulfment and degradation of apoptotic cells, thereby maintaining tissue homeostasis and preventing inflammatory responses.
Why Is apoptotic cell clearance Important in Cell Biology?
Apoptotic cell clearance is vital for preventing the release of autoantigens and inflammatory mediators from dying cells, and its failure contributes to the pathogenesis of numerous human diseases, including atherosclerosis, fibrosis, and autoimmune conditions. Moreover, emerging evidence links efficient efferocytosis to tissue regeneration and the limitation of organ aging, making it a promising therapeutic target.
• Prevents inflammation by safely disposing of apoptotic cells before they undergo secondary necrosis.
• Maintains tissue homeostasis by removing excess or damaged cells during development and adulthood.
• Promotes resolution of inflammation through the production of anti-inflammatory mediators.
• Defective efferocytosis is a hallmark of atherosclerosis and contributes to plaque necrosis.
• Impaired clearance of senescent cells accelerates organ aging and age-related dysfunction.
• Autoimmune diseases such as systemic lupus erythematosus are associated with inefficient clearance of apoptotic debris.
• Efferocytosis in the tumor microenvironment can suppress anti-tumor immunity, making it a target for cancer therapy.
• Mechanical cues via Piezo1 enhance efferocytosis and promote resolution of liver fibrosis.
• Metabolic reprogramming, including arachidonic acid metabolism, is essential for efferocytosis-mediated tissue regeneration.
• RNA N-glycosylation of key factors enables immune evasion and homeostatic efferocytosis.
What Happens During apoptotic cell clearance?
Recognition of apoptotic cells
In simple terms: The first step is that the dying cell exposes 'eat-me' signals, and the phagocyte recognizes them.
Apoptotic cells expose phosphatidylserine (PS) on their outer membrane, which serves as a key 'eat-me' signal. Phagocytes recognize PS either directly via receptors such as TIM-4 and BAI1 or indirectly through bridging molecules like MFGE8, GAS6, and Protein S that link PS to receptors such as MERTK, AXL, and TYRO3. This recognition is highly specific and prevents the engulfment of healthy cells. Recent work has shown that RNA N-glycosylation of certain proteins can modulate this recognition process, enabling immune evasion and homeostatic efferocytosis.
Engulfment and internalization
In simple terms: Once recognized, the phagocyte wraps around the apoptotic cell and takes it inside.
Upon receptor engagement, phagocytes reorganize their actin cytoskeleton to form a phagocytic cup that engulfs the apoptotic cell. This process involves Rho GTPases, such as Rac1 and RhoA, and is regulated by kinases and phosphatases. The internalized apoptotic cell is then contained within a phagosome. Efficient engulfment is critical for preventing the release of intracellular contents that could provoke inflammation.
Maturation and degradation
In simple terms: The engulfed cell is broken down inside the phagocyte.
The phagosome undergoes maturation by fusing with lysosomes, forming a phagolysosome where the apoptotic cell is degraded. This step requires acidification and the activity of proteases and nucleases. The degradation products, including amino acids, nucleotides, and lipids, are recycled for use by the phagocyte or released to surrounding tissues. Metabolic pathways, such as arachidonic acid metabolism, are activated during this phase to support tissue regeneration.
Resolution of inflammation
In simple terms: After eating the dead cell, the phagocyte helps turn off inflammation and promote healing.
Efferocytosis actively promotes the resolution of inflammation by inducing the secretion of anti-inflammatory cytokines such as IL-10 and TGF-beta, while suppressing pro-inflammatory cytokines like TNF-alpha and IL-6. This switch is mediated by signaling pathways downstream of PS receptors and metabolic reprogramming. For example, Piezo1-mediated mechanosensing enhances macrophage efferocytosis and promotes the resolution of liver fibrosis. Defects in this resolution phase can lead to chronic inflammation and tissue damage.
Key Genes Involved in GO:0043277 apoptotic cell clearance
The following table lists key genes and proteins involved in apoptotic cell clearance, along with their major roles and relevance for research.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MERTK | Receptor tyrosine kinase that recognizes PS via bridging molecules | Defective efferocytosis in autoimmune diseases and atherosclerosis |
| AXL | Receptor tyrosine kinase involved in PS recognition | Target for cancer immunotherapy and fibrosis |
| TYRO3 | Receptor tyrosine kinase that binds GAS6 | Regulates macrophage polarization and inflammation |
| MFGE8 | Bridging molecule linking PS to integrins | Polymorphisms linked to autoimmune susceptibility |
| GAS6 | Ligand for TYRO3, AXL, MERTK | Modulates efferocytosis in vascular disease |
| TIM-4 | PS receptor on macrophages | Mediates tethering of apoptotic cells |
| BAI1 | PS receptor involved in engulfment | Regulates phagocytosis in macrophages |
| RAC1 | Rho GTPase regulating actin cytoskeleton during engulfment | Essential for phagocytic cup formation |
| PIEZO1 | Mechanosensitive ion channel | Enhances efferocytosis and resolves liver fibrosis |
| IL10 | Anti-inflammatory cytokine induced by efferocytosis | Promotes resolution of inflammation |
| TGFB1 | Anti-inflammatory cytokine induced by efferocytosis | Suppresses pro-inflammatory responses |
| LC3 | Autophagy protein involved in LC3-associated phagocytosis | Facilitates degradation of apoptotic cells |
| RAB7 | Late endosomal GTPase | Regulates phagosome maturation |
| ATP6V1A | V-ATPase subunit | Acidifies phagolysosomes for degradation |
| C1Q | Complement protein that opsonizes apoptotic cells | Deficiency linked to lupus |
| CRP | C-reactive protein that binds apoptotic cells | Modulates clearance in inflammation |
| ANXA1 | Annexin A1, PS-binding protein | Regulates efferocytosis and inflammation |
| NR1H3 | Liver X receptor, regulates efferocytosis genes | Target for atherosclerosis therapy |
How Is apoptotic cell clearance Regulated?
Apoptotic cell clearance is tightly regulated at multiple levels. Transcriptional regulation involves nuclear receptors such as NR1H3 (LXR), which control the expression of efferocytosis receptors and bridging molecules. Post-translational modifications, including phosphorylation and ubiquitination, modulate the activity of receptors like MERTK and AXL. Metabolic regulation is also critical: arachidonic acid metabolism downstream of efferocytosis supports tissue regeneration, and mechanotransduction via Piezo1 enhances efferocytosis in response to tissue stiffness. Additionally, RNA N-glycosylation of key proteins has emerged as a regulator of homeostatic efferocytosis and immune evasion. Inflammaging, the chronic low-grade inflammation associated with aging, is linked to impaired efferocytosis, and targeting efferocytosis pathways is being explored to mitigate age-related diseases.
apoptotic cell clearance and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MERTK | Atherosclerosis, autoimmune disease | Knockout mouse, macrophage-specific KO |
| PIEZO1 | Liver fibrosis | Conditional knockout, point mutation (gain-of-function) |
| MFGE8 | Autoimmune susceptibility | Knock-in of risk variants, overexpression |
| AXL | Cancer, fibrosis | Kinase-dead knock-in, CRISPR knockout |
| C1Q | Systemic lupus erythematosus | Knockout mouse, human iPSC-derived macrophages |
Atherosclerosis
Defective efferocytosis in atherosclerotic plaques leads to the accumulation of apoptotic cells and necrotic core formation, driving plaque instability and cardiovascular events. Macrophages in advanced plaques often exhibit impaired clearance capacity, contributing to disease progression. Therapeutic strategies aimed at enhancing efferocytosis are being investigated to stabilize plaques and reduce inflammation.
Fibrosis
Impaired clearance of apoptotic cells in the liver promotes fibrosis by sustaining inflammation and activating stellate cells. Recent research shows that Piezo1-mediated mechanosensing enhances macrophage efferocytosis and promotes the resolution of liver fibrosis, suggesting a potential therapeutic target.
Autoimmune disorders
Inefficient clearance of apoptotic debris can lead to the exposure of autoantigens and the development of autoimmune diseases such as systemic lupus erythematosus. Genetic deficiencies in complement components like C1Q or bridging molecules like MFGE8 are associated with increased autoimmune susceptibility.
Aging and inflammaging
Age-related decline in efferocytosis contributes to chronic inflammation, termed inflammaging, and organ dysfunction. Restoring the clearance of senescent neutrophils by tissue-resident macrophages has been shown to limit organ aging in preclinical models. Targeting efferocytosis pathways is therefore a promising approach to promote healthy aging.
From apoptotic cell clearance-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate efferocytosis in macrophages? | CRISPR knockout in macrophage cell lines (e.g., RAW264.7, THP-1) |
| Does a point mutation in gene Y affect PS recognition? | Knock-in of point mutation in iPSCs or cell lines |
| Can overexpression of gene Z enhance clearance? | Lentiviral overexpression in primary macrophages |
| What is the role of gene W in tissue-specific efferocytosis? | Conditional knockout mouse (e.g., LysM-Cre) |
| How does mechanical force regulate efferocytosis? | Piezo1 knock-in or knockout in macrophages under controlled stiffness |
| Can CRISPR screening identify novel efferocytosis regulators? | Genome-wide CRISPR knockout library in phagocytes |
How to Study the apoptotic cell clearance Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Live-cell imaging | Real-time engulfment of apoptotic cells | Visualizing phagocytic cup formation |
| Flow cytometry | Percentage of phagocytes with internalized apoptotic cells | High-throughput screening of efferocytosis regulators |
| CRISPR knockout screen | Genes required for efferocytosis | Discovery of novel pathways |
| Phosphoproteomics | Signaling changes during efferocytosis | Mapping receptor tyrosine kinase pathways |
| Lipidomics | Lipid mediator production | Arachidonic acid metabolism during resolution |
| Seahorse assay | Metabolic flux (OCR/ECAR) | Metabolic reprogramming in phagocytes |
| Immunofluorescence | Localization of PS receptors and bridging molecules | Tissue section analysis of efferocytosis |
Live-cell imaging and flow cytometry
Live-cell imaging allows real-time visualization of apoptotic cell recognition and engulfment by phagocytes, often using fluorescently labeled apoptotic cells (e.g., pHrodo or CFSE). Flow cytometry-based assays quantify the percentage of phagocytes that have internalized apoptotic targets, providing a high-throughput readout for genetic screens.
CRISPR screens
Genome-wide CRISPR knockout or activation screens in macrophage cell lines can identify genes that positively or negatively regulate efferocytosis. These screens typically use apoptotic cells labeled with a fluorescent dye and sort phagocytes that have internalized them, followed by next-generation sequencing to identify enriched sgRNAs.
Proteomics and phosphoproteomics
Mass spectrometry-based proteomics can map the protein composition of phagosomes and identify post-translational modifications that regulate efferocytosis. Phosphoproteomics is particularly useful for dissecting signaling pathways downstream of PS receptors.
Metabolic assays
Seahorse extracellular flux analysis and lipidomics can measure metabolic reprogramming during efferocytosis, such as changes in glycolysis, oxidative phosphorylation, and arachidonic acid metabolism. These assays help link efferocytosis to tissue regeneration and inflammation resolution.
How CRISPR Can Be Used to Study GO:0043277 apoptotic cell clearance
Knockout
CRISPR knockout of candidate genes in macrophage cell lines or primary cells is a powerful approach to determine their requirement for apoptotic cell clearance. For example, knockout of MERTK or AXL abolishes PS recognition and engulfment, leading to accumulation of apoptotic cells. Genome-wide knockout screens have identified numerous novel regulators of efferocytosis.
Point Mutation
Knock-in of disease-associated point mutations (e.g., in MERTK or PIEZO1) allows researchers to study the functional consequences of specific variants on efferocytosis. This is particularly useful for understanding how genetic polymorphisms contribute to autoimmune or cardiovascular diseases.
Knock-in
Tagged knock-in of efferocytosis genes (e.g., GFP or HA tags) enables real-time tracking of protein localization and interaction during clearance. Knock-in of reporter genes under the control of endogenous promoters can also provide readouts of gene expression in live cells.
Overexpression
Overexpression of genes such as MFGE8 or PIEZO1 can enhance efferocytosis and promote resolution of inflammation or fibrosis. This approach is valuable for testing therapeutic potential and for dissecting gain-of-function mechanisms.
How EDITGENE Supports apoptotic cell clearance Research
Researchers studying apoptotic cell clearance-related genes often need to determine whether a candidate gene is causally involved in the recognition, engulfment, or degradation of apoptotic cells. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research, from gene knockout to precise point mutations and overexpression models.
Contact EDITGENE today to design your custom CRISPR model for apoptotic cell clearance research.
Frequently Asked Questions About apoptotic cell clearance
What is apoptotic cell clearance?
Apoptotic cell clearance, also known as efferocytosis, is the biological process by which dying apoptotic cells are recognized and removed by neighboring cells or professional phagocytes.
What genes are involved in apoptotic cell clearance?
Key genes include MERTK, AXL, TYRO3, MFGE8, GAS6, TIM-4, BAI1, RAC1, and PIEZO1, among others.
What is the GO term for apoptotic cell clearance?
The Gene Ontology term is GO:0043277, defined as the recognition and removal of an apoptotic cell by a neighboring cell or by a phagocyte.
Why is efferocytosis important?
Efferocytosis prevents inflammation, maintains tissue homeostasis, and promotes resolution of inflammation; its failure is linked to atherosclerosis, fibrosis, and autoimmune diseases.
How is apoptotic cell clearance regulated?
It is regulated by PS receptors, bridging molecules, metabolic pathways, mechanotransduction, and RNA modifications.
What diseases are associated with defective efferocytosis?
Defective efferocytosis is associated with atherosclerosis, fibrosis, autoimmune disorders, and age-related inflammaging.
What methods are used to study apoptotic cell clearance?
Common methods include live-cell imaging, flow cytometry, CRISPR screens, proteomics, and metabolic assays.
Can CRISPR be used to study efferocytosis genes?
Yes, CRISPR knockout, knock-in, and overexpression models are widely used to dissect the roles of efferocytosis genes.
What is the role of PIEZO1 in efferocytosis?
PIEZO1 is a mechanosensitive ion channel that enhances macrophage efferocytosis and promotes the resolution of liver fibrosis.
How does efferocytosis affect aging?
Restored clearance of senescent neutrophils by macrophages limits organ aging, suggesting that enhancing efferocytosis may promote healthy aging.
Conclusion
Apoptotic cell clearance (GO:0043277) is a fundamental biological process that maintains tissue homeostasis and resolves inflammation. Its dysregulation contributes to a wide range of diseases, including atherosclerosis, fibrosis, autoimmune disorders, and age-related organ dysfunction. Recent research has uncovered new layers of regulation, from mechanotransduction to metabolic reprogramming and RNA modifications. CRISPR-based models are indispensable for dissecting the causal roles of efferocytosis genes and for developing therapeutic strategies. EDITGENE provides comprehensive CRISPR services to support this research, from knockout and knock-in models to library screening and bioinformatics.
References
- 1. Wang Y et al.. 2024. Stiffness sensing via Piezo1 enhances macrophage efferocytosis and promotes the resolution of liver fibrosis.. Sci Adv 10(23):eadj3289 PMID: 38838160
- 2. Elliott MR et al.. 2016. The Dynamics of Apoptotic Cell Clearance.. Dev Cell 38(2):147-60 PMID: 27459067
- 3. Poon IKH et al.. 2024. Targeting Efferocytosis in Inflammaging.. Annu Rev Pharmacol Toxicol 64:339-357 PMID: 37585658
- 4. Adkar SS et al.. 2024. Efferocytosis in atherosclerosis.. Nat Rev Cardiol 21(11):762-779 PMID: 38750215
- 5. Graziano VR et al.. 2025. RNA N-glycosylation enables immune evasion and homeostatic efferocytosis.. Nature 645(8081):784-792 PMID: 40770106
- 6. Ghorbanzadeh S et al.. 2025. Clearing the Path: Exploring Apoptotic Cell Clearance in Inflammatory and Autoimmune Disorders for Therapeutic Advancements.. Mol Biotechnol 67(6):2223-2238 PMID: 38935260
- 7. Lantz C et al.. 2025. Early-age efferocytosis directs macrophage arachidonic acid metabolism for tissue regeneration.. Immunity 58(2):344-361.e7 PMID: 39938482
- 8. Tan YJ et al.. 2026. Restored clearance of senescent neutrophils by tissue-resident macrophages limits organ aging.. Science 393(6808):eaea3075 PMID: 42462036
